King Pharma announces intention to fight Actavis' generic Avinza House, Senate pass patent reform bills; industry opposes Anderson rallies the Rx troops White House opposes part of new patent bill Anderson’s first 100 days spell New Deal for community Rx Cardinal CEO addresses pressing challenges U.S. Chamber lends support in Medicaid payments battle Novartis' third quarter to reflect $250 million-$300 million charge for Teva litigation Massachusetts holds public hearings on in-store clinics Generic industry still hopeful for FDA biogeneric legislation First Previous 657 658 659 660 661 Next Last
